1.Decreased FEF 50 as an indicator of comorbid asthma and persistent airflow limitation in patients with chronic rhinosinusitis with nasal polyps: A cross-sectional study.
Xuechen WANG ; Fangyuan LI ; Chengshuo WANG ; Kai HUANG ; Shen SHEN ; Ming WANG ; Jianmin JIN ; Luo ZHANG
Chinese Medical Journal 2024;137(3):353-355
2.Effect of short course oral glucocorticoids on topical expression of tight junction in chronic rhinosinusitis with nasal polyp
Mu XIAN ; Lei PANG ; Ying LI ; Chengshuo WANG ; Luo ZHANG
Chinese Archives of Otolaryngology-Head and Neck Surgery 2024;31(5):301-304
		                        		
		                        			
		                        			OBJECTIVE To observe the effect of a short course of oral glucocorticoids(GCs)on the expression level of tight junctions(TJs)in the epithelium of nasal polyps.METHODS Patients with chronic rhinosinusitis with nasal polyps(CRSwNP)who were hospitalized for nasal endoscopic surgery were recruited and given oral GCs for 7 consecutive days before surgery.Nasal polyp tissues were harvested before and after GCs treatment respectively.Adult patients who were to undergo nasal endoscopic surgery due to non-inflammatory diseases were selected,and the mucosa of the middle turbinates,inferior turbinates,or uncinate process obtained during surgery was retained as normal controls.Real-time PCR and immunofluorescence confocal microscopy were used to detect the expression of TJs.RESULTS Before oral GCs therapy,the mRNA expression levels of claudin-3,claudin-4,and occludin in nasal polyp specimens were significantly lower than that of normal nasal mucosa.After a short course of oral GCs therapy,the mRNA expression levels of claudin-3 and claudin-4 in nasal polyp specimens were significantly higher than those before treatment.After oral GCs treatment,the protein expression levels of claudin-1 and claudin-4 in nasal polyp tissues were significantly higher than those before treatment.CONCLUSION Compared with normal nasal mucosa,the expression of multiple tight junction proteins in the epithelium of nasal polyps decreases.Short-term oral GCs therapy can significantly up-regulate the expression of tight junction proteins.
		                        		
		                        		
		                        		
		                        	
3.Expert consensus on odontogenic maxillary sinusitis multi-disciplinary treatment
Lin JIANG ; Wang CHENGSHUO ; Wang XIANGDONG ; Chen FAMING ; Zhang WEI ; Sun HONGCHEN ; Yan FUHUA ; Pan YAPING ; Zhu DONGDONG ; Yang QINTAI ; Ge SHAOHUA ; Sun YAO ; Wang KUIJI ; Zhang YUAN ; Xian MU ; Zheng MING ; Mo ANCHUN ; Xu XIN ; Wang HANGUO ; Zhou XUEDONG ; Zhang LUO
International Journal of Oral Science 2024;16(1):1-14
		                        		
		                        			
		                        			Odontogenic maxillary sinusitis(OMS)is a subtype of maxillary sinusitis(MS).It is actually inflammation of the maxillary sinus that secondary to adjacent infectious maxillary dental lesion.Due to the lack of unique clinical features,OMS is difficult to distinguish from other types of rhinosinusitis.Besides,the characteristic infectious pathogeny of OMS makes it is resistant to conventional therapies of rhinosinusitis.Its current diagnosis and treatment are thus facing great difficulties.The multi-disciplinary cooperation between otolaryngologists and dentists is absolutely urgent to settle these questions and to acquire standardized diagnostic and treatment regimen for OMS.However,this disease has actually received little attention and has been underrepresented by relatively low publication volume and quality.Based on systematically reviewed literature and practical experiences of expert members,our consensus focuses on characteristics,symptoms,classification and diagnosis of OMS,and further put forward multi-disciplinary treatment decisions for OMS,as well as the common treatment complications and relative managements.This consensus aims to increase attention to OMS,and optimize the clinical diagnosis and decision-making of OMS,which finally provides evidence-based options for OMS clinical management.
		                        		
		                        		
		                        		
		                        	
4.Differential expression of NEDD8 in different pathological types of chronic rhinosinusitis with nasal polyps.
Chen MENG ; Bing YAN ; Yuqing HUANG ; Chengshuo WANG ; Luo ZHANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2023;37(11):897-901
		                        		
		                        			
		                        			Objective:To analyze the differential expression of neural precursor cell-expressed developmentally downregulated 8(NEDD8) protein in nasal polyp tissues of patients with different pathological types of chronic rhinorhinosinusitis with nasal polyps(CRSwNP). Methods:All specimens were obtained from the specimen library of Beijing Tongren Hospital, and were all patients who underwent nasal endoscopic surgery for chronic rhinosinusitis in Beijing Tongren Hospital. Hematoxylin-eosin staining(HE) was used to detect the number of eosinophils in nasal polyps, and CRSwNP patients were grouped according to the number of eosinophils in nasal polyps, immunohistochemistry was used to detect and analyze the expression level of NEDD8 protein in nasal polyps. Results:The expression level of NEDD8 protein in nasal polyps of patients with eosinophilic chronic rhinorhinosinusitis with nasal polyps was significantly higher than that of patients with non-eosinophilic chronic rhinosinusitis and nasal polyps(P<0.05). In addition, there was a significant positive correlation between the expression level of NEDD8 protein and the number of eosinophils in nasal polyp tissue(r=0.79, P=0.02). Conclusion:There are differences in the expression of NEDD8 protein in patients with chronic rhinosinusitis and nasal polyps of different pathological types.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Nasal Polyps/metabolism*
		                        			;
		                        		
		                        			Rhinitis/diagnosis*
		                        			;
		                        		
		                        			NEDD8 Protein/metabolism*
		                        			;
		                        		
		                        			Sinusitis/diagnosis*
		                        			;
		                        		
		                        			Eosinophils/metabolism*
		                        			;
		                        		
		                        			Chronic Disease
		                        			
		                        		
		                        	
5.Analysis of potential diagnostic genes for eosinophilic chronic rhinosinusitis with nasal polyps based on GEO datasets
Yuqing HUANG ; Chen MENG ; Jianhong LIAO ; Bing YAN ; Luo ZHANG ; Chengshuo WANG
Chinese Archives of Otolaryngology-Head and Neck Surgery 2023;30(12):781-784
		                        		
		                        			
		                        			OBJECTIVE To utilize RNA sequencing(RNA-seq)data from the GEO database to identify genes with potential diagnostic value for eosinophilic chronic rhinosinusitis with nasal polyps(ECRSwNP).METHODS Three datasets were obtained,and samples were divided into ECRSwNP and nonECRSwNP groups based on the expression levels of CST1 and CLC.A diagnostic model for ECRSwNP was established using R software and algorithms,and its accuracy was assessed.RESULTS The samples were grouped as follows:GSE136825(ECRSwNP 7,nonECRSwNP 19),GSE72713(ECRSwNP 3,nonECRSwNP 3),and GSE179265(ECRSwNP 11,nonECRSwNP 2).The diagnostic performance of the upregulated gene model(ADH1C,CCL26,HRH1,NOS2)and the downregulated gene model(LCN2,MUC5B,PLAT,TMEM45A,XDH)constructed based on the support vector machine(SVM)algorithm for ECRSwNP was excellent.CONCLUSION The diagnostic genes identified by the SVM model may serve as biological markers for the non-invasive diagnosis of ECRSwNP and potentially play a crucial role in the pathogenesis of ECRSwNP.
		                        		
		                        		
		                        		
		                        	
6.Analysis of the diagnosis and treatment of patients with SMARCB1 (INI-1)-deficient sinonasal carcinoma
Lingwa WANG ; Ru WANG ; Jugao FANG ; Qi ZHONG ; Lizhen HOU ; Hongzhi MA ; Ling FENG ; Shizhi HE ; Chengshuo WANG ; Luo ZHANG
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2022;57(7):848-853
		                        		
		                        			
		                        			Objective:To summarize the clinical features, treatments and outcomes of patients with SMARCB1(INI-1)-deficient sinonasal carcinoma (SDSC).Methods:Fifteen patients who were diagnosed as SDSC in Beijing Tongren Hospital from October 2016 to June 2021 were retrieved, including nine males and six females, ranged from 25 to 78 years old. For TNM stage, one case was in stage T2, one case was in stage T3, 13 cases were in stage T4; 13 cases were in stage N0, two cases were in stage N2; 14 cases were in stage M0, one case was in stage M1. The most common paranasal sinus affected by tumor was the ethmoid sinus. Five patients were treated by radical surgical resection combined with postoperative adjuvant therapy, four patients treated by neoadjuvant therapy with surgical resection, three patients treated by surgical resection only, one patient treated by neoadjuvant therapy with concurrent chemoradiotherapy, one patient treated by preoperative radiotherapy with surgery, and one patient received palliative chemotherapy. Immunohistochemical analysis was performed in all cases. The Kaplan-Meier method was used to draw the survival curve, and the Log-rank test was used to compare the difference to 20 undifferentiated carcinoma patients with positive INI-1 expression in the same period.Results:Immunohistochemical analysis showed the complete absence of INI-1 expression in the tumor nuclei in all 15 cases. The follow-up information was available with a median follow-up time of 21 months (3-56 months). The 3-year overall survival rate, disease specific survival rate, disease-free survival rate and metastasis-free survival rate were 58.9%, 58.9%, 36.4% and 31.2%, respectively. Disease-free survival in SDSC patients was significantly lower compared with undifferentiated carcinoma patients with positive INI-1 expression ( HR=2.87,95% CI:0.92~8.91, P=0.043). Cox regression analysis showed that patients with comprehensive treatment based on surgery had a better prognosis than others ( HR=8.61,95% CI:1.38~53.73, P=0.021). Conclusion:SDSC is a highly aggressive malignant tumor with the characteristics of easy recurrence, early metastasis and poor prognosis. INI-1 immunohistochemical analysis is recommended in the pathologically poorly differentiated sinonasal carcinoma. Comprehensive treatment based on radical resection may be the first choice for SDSC patients.
		                        		
		                        		
		                        		
		                        	
7.A randomized controlled trial to compare the efficacy of regenerated and non-regenerated oxidized cellulose gauze for the secondary treatment of local bleeding in patients undergoing hepatic resection
Chengshuo ZHANG ; Dazhi FU ; Fengshan WANG ; Xinping ZHONG ; Lei YANG ; Gang WU ; Baifeng LI ; Jialin ZHANG
Annals of Surgical Treatment and Research 2021;100(4):193-199
		                        		
		                        			Purpose:
		                        			Oxidized cellulose is available in many forms, but manufactured using either a regenerated or non-regenerated process. In this study, we evaluated the effects of 2 different hemostatic agents for the treatment of local bleeding in patients undergoing hepatic resection. 
		                        		
		                        			Methods:
		                        			This was a monocentric, parallel-group, randomized, and controlled clinical trial to compare oxidized regenerated cellulose gauze (ORCG) with oxidized non-regenerated cellulose gauze (ONRCG) in patients undergoing hepatectomy. The primary endpoint was the time to hemostasis at the target bleeding site. The secondary endpoints were the postoperative drainage volume on the first 2 days after surgery and the hospital stay. 
		                        		
		                        			Results:
		                        			There was no significant difference between the ORCG and ONRCG groups in time to hemostasis from column analysis (238.8 ± 121.6 seconds vs. 193.7 ± 85.3 seconds, P = 0.068), and there were no differences in the rates of hemostatic success between the 2 groups at 120 seconds (18.4% vs. 24.3%; odds ratio [OR], 0.703; 95% confidence interval [CI], 0.231–2.136) and 300 seconds (71.1% vs. 89.2%; OR, 0.298; 95% CI, 0.085–1.041). However, the ONRCG group was superior to the ORCG group in hemostasis according to the survival analysis (log-rank test, P = 0.044). Moreover, there were also no significant differences between the 2 groups in postoperative drainage volume on the first 2 days (P = 0.436, P = 0.381) and hospital stay (P = 0.537, P = 0.200). 
		                        		
		                        			Conclusion
		                        			ONRCG was not inferior to ORCG as a hemostatic agent in patients undergoing liver resection.
		                        		
		                        		
		                        		
		                        	
8.A randomized controlled trial to compare the efficacy of regenerated and non-regenerated oxidized cellulose gauze for the secondary treatment of local bleeding in patients undergoing hepatic resection
Chengshuo ZHANG ; Dazhi FU ; Fengshan WANG ; Xinping ZHONG ; Lei YANG ; Gang WU ; Baifeng LI ; Jialin ZHANG
Annals of Surgical Treatment and Research 2021;100(4):193-199
		                        		
		                        			Purpose:
		                        			Oxidized cellulose is available in many forms, but manufactured using either a regenerated or non-regenerated process. In this study, we evaluated the effects of 2 different hemostatic agents for the treatment of local bleeding in patients undergoing hepatic resection. 
		                        		
		                        			Methods:
		                        			This was a monocentric, parallel-group, randomized, and controlled clinical trial to compare oxidized regenerated cellulose gauze (ORCG) with oxidized non-regenerated cellulose gauze (ONRCG) in patients undergoing hepatectomy. The primary endpoint was the time to hemostasis at the target bleeding site. The secondary endpoints were the postoperative drainage volume on the first 2 days after surgery and the hospital stay. 
		                        		
		                        			Results:
		                        			There was no significant difference between the ORCG and ONRCG groups in time to hemostasis from column analysis (238.8 ± 121.6 seconds vs. 193.7 ± 85.3 seconds, P = 0.068), and there were no differences in the rates of hemostatic success between the 2 groups at 120 seconds (18.4% vs. 24.3%; odds ratio [OR], 0.703; 95% confidence interval [CI], 0.231–2.136) and 300 seconds (71.1% vs. 89.2%; OR, 0.298; 95% CI, 0.085–1.041). However, the ONRCG group was superior to the ORCG group in hemostasis according to the survival analysis (log-rank test, P = 0.044). Moreover, there were also no significant differences between the 2 groups in postoperative drainage volume on the first 2 days (P = 0.436, P = 0.381) and hospital stay (P = 0.537, P = 0.200). 
		                        		
		                        			Conclusion
		                        			ONRCG was not inferior to ORCG as a hemostatic agent in patients undergoing liver resection.
		                        		
		                        		
		                        		
		                        	
9.Chinese Society of Allergy and Chinese Society of Otorhinolaryngology-Head and Neck Surgery Guideline for Chronic Rhinosinusitis
Zheng LIU ; Jianjun CHEN ; Lei CHENG ; Huabin LI ; Shixi LIU ; Hongfei LOU ; Jianbo SHI ; Ying SUN ; Dehui WANG ; Chengshuo WANG ; Xiangdong WANG ; Yongxiang WEI ; Weiping WEN ; Pingchang YANG ; Qintai YANG ; Gehua ZHANG ; Yuan ZHANG ; Changqing ZHAO ; Dongdong ZHU ; Li ZHU ; Fenghong CHEN ; Yi DONG ; Qingling FU ; Jingyun LI ; Yanqing LI ; Chengyao LIU ; Feng LIU ; Meiping LU ; Yifan MENG ; Jichao SHA ; Wenyu SHE ; Lili SHI ; Kuiji WANG ; Jinmei XUE ; Luoying YANG ; Min YIN ; Lichuan ZHANG ; Ming ZHENG ; Bing ZHOU ; Luo ZHANG
Allergy, Asthma & Immunology Research 2020;12(2):176-237
		                        		
		                        			
		                        			The current document is based on a consensus reached by a panel of experts from the Chinese Society of Allergy and the Chinese Society of Otorhinolaryngology-Head and Neck Surgery, Rhinology Group. Chronic rhinosinusitis (CRS) affects approximately 8% of Chinese adults. The inflammatory and remodeling mechanisms of CRS in the Chinese population differ from those observed in the populations of European descent. Recently, precision medicine has been used to treat inflammation by targeting key biomarkers that are involved in the process. However, there are no CRS guidelines or a consensus available from China that can be shared with the international academia. The guidelines presented in this paper cover the epidemiology, economic burden, genetics and epigenetics, mechanisms, phenotypes and endotypes, diagnosis and differential diagnosis, management, and the current status of CRS in China. These guidelines—with a focus on China—will improve the abilities of clinical and medical staff during the treatment of CRS. Additionally, they will help international agencies in improving the verification of CRS endotypes, mapping of eosinophilic shifts, the identification of suitable biomarkers for endotyping, and predicting responses to therapies. In conclusion, these guidelines will help select therapies, such as pharmacotherapy, surgical approaches and innovative biotherapeutics, which are tailored to each of the individual CRS endotypes.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Asian Continental Ancestry Group
		                        			;
		                        		
		                        			Biomarkers
		                        			;
		                        		
		                        			China
		                        			;
		                        		
		                        			Consensus
		                        			;
		                        		
		                        			Diagnosis
		                        			;
		                        		
		                        			Diagnosis, Differential
		                        			;
		                        		
		                        			Drug Therapy
		                        			;
		                        		
		                        			Eosinophils
		                        			;
		                        		
		                        			Epidemiology
		                        			;
		                        		
		                        			Epigenomics
		                        			;
		                        		
		                        			Genetics
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypersensitivity
		                        			;
		                        		
		                        			Inflammation
		                        			;
		                        		
		                        			International Agencies
		                        			;
		                        		
		                        			Medical Staff
		                        			;
		                        		
		                        			Neck
		                        			;
		                        		
		                        			Phenotype
		                        			;
		                        		
		                        			Precision Medicine
		                        			
		                        		
		                        	
10.Particulate Matter 2.5 Causes Deficiency in Barrier Integrity in Human Nasal Epithelial Cells
Mu XIAN ; Siyuan MA ; Kuiji WANG ; Hongfei LOU ; Yang WANG ; Luo ZHANG ; Chengshuo WANG ; Cezmi A AKDIS
Allergy, Asthma & Immunology Research 2020;12(1):56-71
		                        		
		                        			
		                        			PURPOSE: The effect of air pollution-related particulate matter (PM) on epithelial barrier function and tight junction (TJ) expression in human nasal mucosa has not been studied to date. This study therefore aimed to assess the direct impact of PM with an aerodynamic diameter less than 2.5 μm (PM2.5) on the barrier function and TJ molecular expression of human nasal epithelial cells. METHODS: Air-liquid interface cultures were established with epithelial cells derived from noninflammatory nasal mucosal tissue collected from patients undergoing paranasal sinus surgery. Confluent cultures were exposed to 50 or 100 µg/mL PM2.5 for up to 72 hours, and assessed for 1) epithelial barrier integrity as measured by transepithelial resistance (TER) and permeability of fluorescein isothiocyanate (FITC) 4 kDa; 2) expression of TJs using real-time quantitative polymerase chain reaction and immunofluorescence staining, and 3) proinflammatory cytokines by luminometric bead array or enzyme-linked immunosorbent assay. RESULTS: Compared to control medium, 50 and/or 100 µg/mL PM2.5-treatment 1) significantly decreased TER and increased FITC permeability, which could not be restored by budesonide pretreatment; 2) significantly decreased the expression of claudin-1 messenger RNA, claudin-1, occludin and ZO-1 protein; and 3) significantly increased production of the cytokines interleukin-8, TIMP metallopeptidase inhibitor 1 and thymic stromal lymphopoietin. CONCLUSIONS: Exposure to PM2.5 may lead to loss of barrier function in human nasal epithelium through decreased expression of TJ proteins and increased release of proinflammatory cytokines. These results suggest an important mechanism of susceptibility to rhinitis and rhinosinusitis in highly PM2.5-polluted areas.
		                        		
		                        		
		                        		
		                        			Asthma
		                        			;
		                        		
		                        			Budesonide
		                        			;
		                        		
		                        			Claudin-1
		                        			;
		                        		
		                        			Cytokines
		                        			;
		                        		
		                        			Enzyme-Linked Immunosorbent Assay
		                        			;
		                        		
		                        			Epithelial Cells
		                        			;
		                        		
		                        			Fluorescein
		                        			;
		                        		
		                        			Fluorescein-5-isothiocyanate
		                        			;
		                        		
		                        			Fluorescent Antibody Technique
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Interleukin-8
		                        			;
		                        		
		                        			Mucous Membrane
		                        			;
		                        		
		                        			Nasal Mucosa
		                        			;
		                        		
		                        			Occludin
		                        			;
		                        		
		                        			Particulate Matter
		                        			;
		                        		
		                        			Permeability
		                        			;
		                        		
		                        			Polymerase Chain Reaction
		                        			;
		                        		
		                        			Rhinitis
		                        			;
		                        		
		                        			RNA, Messenger
		                        			;
		                        		
		                        			Tight Junctions
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail